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AMPA receptor plasticity in accumbens core contributes to 
incubation of methamphetamine craving
Andrew F. Scheyer*, Jessica A. Loweth*, Daniel T. Christian*, Jamie Uejima, Rana Rabei, 
Tuan Le, Hubert Dolubizno, Michael T. Stefanik, Connor H. Murray, Courtney Sakas, and 
Marina E. Wolf
Department of Neuroscience, The Chicago Medical School at Rosalind Franklin University of 
Medicine and Science, North Chicago, IL 60064, USA
Abstract
BACKGROUND—The incubation of cue-induced drug craving in rodents provides a model of 
persistent vulnerability to craving and relapse in human addicts. After prolonged withdrawal, 
incubated cocaine craving depends on strengthening of nucleus accumbens (NAc) core synapses 
through incorporation of Ca2+-permeable AMPA receptors (CP-AMPARs). Through mGlu1-
mediated synaptic depression, mGlu1 positive allosteric modulators (PAMs) remove CP-AMPARs 
from these synapses and thereby reduce cocaine craving. This study aimed to determine if similar 
plasticity accompanies incubation of methamphetamine craving.
METHODS—Rats self-administered saline or methamphetamine under extended-access 
conditions. Cue-induced seeking tests demonstrated incubation of methamphetamine craving. 
After withdrawal periods ranging from 1 to >40 days, rats underwent one of the following 
procedures: 1) whole-cell patch clamp recordings to characterize AMPAR transmission, 2) intra-
NAc core injection of the CP-AMPAR antagonist 1-napthyl acetyl spermine (naspm) prior to a 
seeking test, or 3) systemic administration of an mGlu1 PAM prior to a seeking test.
RESULTS—Incubation of methamphetamine craving was associated with CP-AMPAR 
accumulation in NAc core, and both effects were maximal after ~1 week of withdrawal. 
Expression of incubated craving was decreased by intra-NAc naspm injection or systemic mGlu1 
PAM administration.
CONCLUSIONS—These results are the first to demonstrate a role for the NAc in the incubation 
of methamphetamine craving and describe adaptations in synaptic transmission associated with 
this model. They establish that incubation of craving and associated CP-AMPAR plasticity occur 
much more rapidly during withdrawal from methamphetamine than cocaine. However, a common 
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mGlu1-based therapeutic strategy may be helpful for recovering cocaine and methamphetamine 
addicts.
Keywords
Ca2+-permeable AMPA receptors; extended-access drug self-administration; metabotropic 
glutamate receptor 1 (mGlu1); incubation of craving; methamphetamine; nucleus accumbens
Introduction
Methamphetamine addiction is a serious public health problem. Its long-term abuse leads to 
alterations in brain circuitry and cognitive function that are associated with a high likelihood 
of relapse, even after prolonged abstinence (1,2). In a rodent model of this persistent 
vulnerability to relapse, termed the incubation model, cue-induced drug craving 
progressively increases (incubates) during abstinence from drug self-administration and can 
remain high for months. Incubation of cue-induced craving has been demonstrated in 
rodents during forced abstinence/withdrawal (the terms will be used interchangeably) 
following extended-access self-administration of methamphetamine as well as cocaine, 
heroin, ethanol and nicotine (3–5). Incubation of craving also occurs during forced 
abstinence in humans addicted to methamphetamine (6), nicotine (7), and alcohol (8). 
Recently, rodent studies have shown that incubation of methamphetamine craving occurs not 
only during forced abstinence, but also when abstinence is self-imposed, either because 
drug-taking is punished (9) or because animals are forced to choose between 
methamphetamine and a food reward (10). Together, these findings establish that the 
incubation of craving model is relevant to understanding why methamphetamine users 
remain vulnerable to cue-induced craving and relapse long after achieving abstinence, 
regardless of whether abstinence results from incarceration or hospitalization (forced 
abstinence), a desire to avoid negative consequences associated with drug use, or a transition 
to alternative sources of reinforcement.
While the cellular basis of incubation of cocaine craving has been extensively studied (5), 
less is known about mechanisms mediating the incubation of methamphetamine craving (see 
Discussion). Regarding the underlying neural circuitry, it was found that reversible 
inactivation of the central nucleus of the amygdala (CeA), but not other regions tested 
[dorsal medial prefrontal cortex (mPFC), ventral mPFC, and orbitofrontal cortex], impaired 
the expression of incubated methamphetamine craving (11). Thus, there is partial overlap 
with incubation of cocaine craving, which requires both CeA and mPFC activation for its 
expression (12–14). Another study found that D1 dopamine receptor transmission in the 
dorsal striatum was required for the expression of incubated methamphetamine craving (15). 
Surprisingly, the nucleus accumbens (NAc), which plays a critical role in the expression of 
incubated cocaine craving after prolonged withdrawal (see next paragraph), has yet to be 
evaluated for a role in the incubation of methamphetamine craving. While inactivation of the 
NAc core was shown to eliminate cue-and methamphetamine-induced reinstatement of drug-
seeking after extended-access methamphetamine self-administration and extinction training 
(16), extinction training and forced abstinence can engage different circuits and produce 
different neuroadaptations (see Discussion).
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In drug-naïve or saline treated animals, GluA2-containing Ca2+-impermeable AMPA 
receptors (CI-AMPARs) are largely responsible for excitatory transmission onto medium 
spiny neurons (MSN), the output neurons of the NAc (17,18). However, after ~1 month of 
withdrawal from extended-access cocaine self-administration, high conductance Ca2+-
permeable AMPARs (CP-AMPARs) accumulate in NAc core synapses (18–23) and 
thereafter their activation is required for the expression of incubated cocaine craving (18,23). 
This is consistent with other evidence that enhanced activation of NAc core MSN is critical 
for incubation (24–26), as well as cocaine seeking in other models (e.g., 27,28). CP-AMPAR 
plasticity occurs in concert with plasticity of group I mGlu-mediated synaptic depression in 
the NAc core. Control rats exhibit mGlu5-dependent synaptic depression that is expressed 
presynaptically via cannabinoid receptor 1 stimulation (29). In “cocaine incubated rats”, this 
is impaired and instead we observe mGlu1-dependent synaptic depression that is expressed 
postsynaptically via CP-AMPAR endocytosis (20,30). Using mGlu1 positive allosteric 
modulators (PAMs), this mGlu1-dependent synaptic depression can be targeted to remove 
CP-AMPARs from NAc synapses and thus reduce cue-induced cocaine craving (23), 
offering a potential strategy to help recovering users maintain abstinence (5,31). Here we 
determined whether elevated CP-AMPAR levels and mGlu1-mediated synaptic depression 
can be demonstrated in the NAc core after incubation of methamphetamine craving and 
whether the latter mechanism can be targeted to reduce methamphetamine craving.
Methods and Materials
Subjects and Surgery
All experimental procedures were approved by the Rosalind Franklin University Institutional 
Animal Care and Use Committee in accordance with the USPHS Guide for Care and Use of 
Laboratory Animals. Adult male Sprague-Dawley rats (Harlan, Indianapolis, IN), 250–275 g 
upon arrival, were housed 3/cage under a reverse 12-h light-dark cycle. Jugular catheter 
surgery was performed as described previously (18) (see Supplemental Methods). For rats 
destined for the experiment using 1-naphthyl acetyl spermine (naspm), following jugular 
catheterization, guide cannulae (23-gauge, Plastics One) were implanted bilaterally 1.5 mm 
above the NAc core. Coordinates were: AP −1.4 mm, ML ±2.5 mm (6° angle), DV −5.5 mm 
(32).
Drug self-administration training
Rats were trained to self-administer methamphetamine or saline (control condition) during a 
total of 10 daily sessions, each lasting 6 h, conducted over 11–12 days with 1–2 days off, 
under a fixed-ratio-1 reinforcement schedule. Sessions began at the onset of the dark cycle. 
Methamphetamine (dissolved in saline) was self-administered at a dose of 0.1 mg/kg/
infusion (0.065 mL/infusion). Control rats self-administered saline (0.065 mL/infusion) 
under the same schedule. Self-administration was conducted in operant chambers equipped 
with two nose-poke holes. Active hole responses activated the infusion pump and led to the 
delivery of a 20-sec light cue (white light illuminating the active hole). Each infusion was 
followed by a 20-sec timeout period. Nose poking in the inactive hole had no consequences. 
For additional details, see Supplemental Methods.
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Tests for cue-induced methamphetamine seeking
For experiments involving seeking tests, rats were divided into groups matched for mean 
number of infusions and active hole responses during training. They were returned to the 
self-administration chambers on the specified withdrawal day during the dark cycle and 
tested for 30 min under extinction conditions, i.e., nose pokes in the previously active hole 
resulted in presentations of the light cue previously paired with methamphetamine, but 
methamphetamine was not delivered. The number of responses in the previously active hole 
was used as a measure of methamphetamine seeking or craving. For experiments that 
evaluated the effect of the systemically active mGlu1 PAM SYN119 (33) on cue-induced 
methamphetamine seeking, rats received an injection of vehicle or SYN119 [10 mg/kg, 
intraperitoneal (i.p.)] 20 min before placement in the operant chamber. During the 20-min 
post-injection period, they were returned to their home cage. This 20-min period was 
determined on the basis of the half-life of SYN119 (55 min; ref 34) and on the basis of our 
prior positive results in similar cocaine studies (23). For the WD1 seeking tests, each rat 
received one seeking test and one injection (SYN119 or vehicle). For the late withdrawal 
seeking tests, vehicle and SYN119 injection groups were counterbalanced, with all rats 
receiving 2 seeking tests and 2 injections (SYN119 and vehicle), 8 days apart (on WD44 and 
WD52). Counterbalancing was not feasible in early withdrawal. For the experiment that 
evaluated the effect of intra-NAc core infusion of naspm (on WD45), intracranial injections 
of naspm (40 μg/site, injection volume 0.5 μl) were made as described previously (18), 15 
min before the start of the 30-min seeking test (see Supplemental Methods). Each rat 
received only one intra-NAc infusion (naspm or vehicle).
Whole-cell patch-clamp recordings
Electrophysiological procedures were described previously (18–23) and are detailed in 




Data are expressed as mean ± SEM. Student’s t-tests (unpaired unless otherwise indicated) 
were used for comparing two groups whereas ANOVA was used for comparing multiple 
groups. Differences between experimental conditions were considered statistically 
significant when p<0.05.
Results
Incubation of methamphetamine craving
Rats were trained to self-administer methamphetamine (10 total sessions of 6 h/day) and 
tested for cue-induced methamphetamine craving on either WD1 (n=13) or WD45 (n=13) 
(Figure 1A). Self-administration training was staggered so that the WD1 group was tested on 
the same day as the WD45 group. Rats assigned to these groups did not differ during 
training (Figure 1B). We found a significant increase in the number of nose-pokes in the 
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active hole during the seeking test on WD45 compared to WD1 (t24=3.48, p=0.002), but no 
significant difference for inactive hole responding (p>0.05) (Figure 1C). These results 
establish that our methamphetamine regimen leads to incubation of methamphetamine 
craving, as found with similar regimens (11,15,35).
CP-AMPARs and mGlu1-mediated synaptic depression emerge after incubation
To determine whether the incubation of methamphetamine craving is associated with CP-
AMPAR accumulation, whole-cell patch-clamp recordings of NAc core MSN were 
conducted following >40 days of withdrawal from extended-access methamphetamine or 
saline self-administration (Figure 2A). This timing was chosen because elevation of CP-
AMPAR levels in the NAc is stable from WD35 through at least WD90 in rats that have 
undergone incubation of cocaine craving (36). Recordings were performed using different 
rats from those depicted in Figure 1, but self-administration training data for these rats were 
very similar to data in Figure 1B. The contribution of CP-AMPARs to synaptic transmission 
was determined by bath application of the CP-AMPAR blocker naspm (100μM). Naspm 
produced a small inhibition of the EPSC−70mV in MSN from saline controls (8.8%, n=6 
cells/4 rats) (Figure 2B), consistent with our previous results indicating that CP-AMPARs 
are responsible for ~5–10% of the evoked EPSC in drug-naïve rats (18,21,22). In contrast, 
naspm application produced a significantly larger reduction in the EPSC−70mV in MSN 
recorded from methamphetamine rats on >WD40 (24.3%, 8 cells/5 rats; t12=3.3, p=0.006, 
methamphetamine group versus saline controls) (Figure 2B). Thus, after >WD40, incubation 
of methamphetamine craving is accompanied by an increase in the CP-AMPAR contribution 
to the EPSC−70mV at excitatory synapses onto NAc core MSN, as reported previously for 
incubation of cocaine craving (18–23).
Whereas mGlu1 activation has no significant effect on excitatory synaptic transmission in 
NAc core MSN of drug-naïve rats, it produces synaptic depression in NAc core MSN 
recorded after incubation of cocaine craving (20,23); this synaptic depression is expressed 
postsynaptically via removal of CP-AMPARs that accumulate during incubation (20,23,30). 
To determine whether mGlu1-mediated synaptic depression was similarly observed in NAc 
core MSN after incubation of methamphetamine craving, the mGlu1 PAM SYN119 (SYN; 
1μM) was bath-applied and found to produce a significant depression of the EPSC−70mV 
(28%, 6 cells/3 rats; t5=9.96, p=0.00018, paired t-test, last 4 min of SYN alone versus last 4 
min of pre-SYN baseline) (Figure 2C). Subsequent application of naspm failed to produce a 
further decrease (1.2%, n=6 cells/3 rats; t5=0.436, p>0.05, paired t-test, last 4 min of SYN 
alone versus last 4 min of naspm), which we interpret to indicate that SYN had already 
removed CP-AMPARs from NAc synapses. Therefore, we conclude that mGlu1 activation 
eliminates the elevated contribution of CP-AMPARs to the EPSC–70mV that is observed in 
“methamphetamine incubated rats”.
Systemic administration of an mGlu1 PAM reduces incubated cue-induced 
methamphetamine seeking after >WD40
Having shown that mGlu1 activation attenuates CP-AMPAR-mediated transmission in vitro 
(Figure 2), we assessed whether enhancing NAc mGlu1 function in vivo would reduce 
incubated cue-induced methamphetamine craving. A new group of rats (n=20) was trained to 
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self-administer methamphetamine as described above (10 total sessions of 6 h/day) (Figure 
3A,B). Rats then underwent withdrawal in their home cages and, after >40 days of 
withdrawal, received an injection of SYN119 (10 mg/kg, i.p.) or vehicle 20 min prior to a 
30-min seeking test, as described previously (23). Vehicle and SYN119 injection groups 
were counterbalanced, with all rats receiving 2 seeking tests, 8 days apart. Our previous 
results establish that residual effects of a single SYN119 injection dissipate within 2 days 
(23). Rats that received SYN119 prior to the seeking test showed a significant reduction in 
active hole responding compared to vehicle-injected controls (paired t-test, t19=2.44, 
p=0.025), with no group differences in inactive hole responding (p>0.05) (Figure 3C). Thus, 
systemic injection of an mGu1 PAM reduces the expression of incubated methamphetamine 
craving, as shown previously for cocaine (23).
Naspm injection into the NAc core reduces incubated cue-induced methamphetamine 
seeking on WD45
To investigate whether the reduction in cue-induced methamphetamine craving elicited by 
SYN119 was mediated by removal of CP-AMPARs from NAc synapses, as suggested by our 
electrophysiological results (Figure 2C), we asked whether directly blocking CP-AMPARs 
in the NAc core with naspm would produce a similar reduction. We targeted the core 
subregion because of its critical role in drug-seeking (see Introduction) and because naspm 
or mGlu1 PAM injection into the core decreased the expression of incubated cue-induced 
cocaine seeking (18,23). For this experiment, a new group of rats was implanted with 
bilateral guide cannulae over the NAc core at the same time as surgery for jugular catheter 
implantation. After recovery, rats (n=26) were trained to self-administer methamphetamine 
(Figure 4A). There was no significant difference between rats destined for the naspm group 
(n=14) versus the vehicle group (n=12) (Figure 4B). On WD45, we injected naspm or 
vehicle into the NAc core bilaterally 15 min prior to a 30-min seeking test. The naspm group 
showed significantly less responding in the active hole (t24=2.60, p=0.016), whereas no 
significant difference was found for inactive hole responding (p>0.05) (Figure 4C). For this 
study, two separate experiments were run at different times. Due to differences in raw data 
values between these experiments, data were normalized to the vehicle control group within 
each experiment and then combined. This explains why inactive hole responses in the 
vehicle group appear as high as active hole responses in Figure 4C; both are set at 100%. 
Histological analysis was performed to confirm cannulae placement in the NAc core (not 
shown), and only rats with confirmed placements were included in the analysis.
Incubation and CP-AMPAR elevation develop rapidly after discontinuing 
methamphetamine self-administration
After cocaine self-administration, incubation of craving begins within the first week of 
abstinence (37), whereas CP-AMPAR elevation is first detected after ~1 month of abstinence 
(36). We determined whether these changes occur with a similar time-course during 
methamphetamine withdrawal, beginning with CP-AMPAR plasticity. A new group of rats 
was used. On WD1, the reduction in EPSC−70mV produced by naspm (4.2 ± 4.0%, n=6 
cells/4 rats, black circles in Figure 5B) did not differ from that observed in saline controls 
(8.8 ± 2.0%, n=6 cells/4 rats, open squares in Figure 2B; t10=1.04, p>0.05, 
methamphetamine WD1 versus saline) and was in the range reported previously for other 
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saline controls (18,21,22). Furthermore, systemic administration of the mGlu1 PAM 
SYN119 had no effect on cue-induced seeking on WD1 (vehicle, 11.9±1.3, n=14 rats; SYN, 
8.5±1.7, n=15 rats; t27=1.5, p>0.05; vehicle versus SYN, active hole responses). Thus, as 
expected, CP-AMPARs remain at control levels on WD1 from methamphetamine self-
administration. However, to our surprise, CP-AMPARs accumulated to maximal levels by 
WD7–8. This was determined by comparing naspm sensitivity in groups of rats recorded on 
WD1, WD2–4, WD7–8, and WD>40 (Figure 5B). A significant group effect was found 
(F3,20=6.03, p=0.004) and LSD post-hoc tests revealed significantly greater naspm 
sensitivity on WD7–8 (20.6% reduction in EPSC−70mV; n=5 cells/4 rats) and WD>40 
(24.3%; n=8 cells/5 rats, black squares in Figure 2B) compared to WD1 (4.2%; see above), 
and no significant difference between WD7–8 and WD>40 (p>0.05). The latter group 
included rats tested as late as WD53. If we binned the >WD40 rats into two groups, WD40–
46 and WD46–53, a t-test revealed no significant difference between these groups (p>0.05). 
A trend towards increased naspm sensitivity was found on WD2–4 (15.2%; n=5 cells/4 rats; 
p>0.05 versus WD1). We then compared cue-induced methamphetamine seeking using a 
within-subjects design (n=12 rats) on WD7 and WD30 and found that it also reached 
maximal levels by WD7 (t11=0.04, p>0.05, WD7 versus WD30, paired t-test, active hole 
responses; Figure 5E; seeking was also comparable to WD45 data in Figure 1 and the 
>WD40 vehicle group in Figure 3C). Thus, incubation of craving and CP-AMPAR 
accumulation in the NAc core occur rapidly and in parallel after discontinuing 
methamphetamine self-administration.
Discussion
Our goal was to determine if the same CP-AMPAR plasticity implicated in the incubation of 
cocaine craving is also important for incubation of methamphetamine craving. This would 
help determine if common therapeutic approaches might be useful for abstinent 
methamphetamine and cocaine addicts.
Common AMPAR adaptations in NAc core after incubation of cocaine and 
methamphetamine craving
To investigate the role of CP-AMPARs in methamphetamine incubation, we began by 
studying “methamphetamine incubated rats” after >40 days of withdrawal because elevation 
of CP-AMPAR levels in the NAc core of “cocaine incubated rats” is stable from WD35 
through at least WD90 (36). At this late withdrawal time, our results demonstrate similarities 
between mechanisms underlying incubation of cocaine and methamphetamine craving. Most 
notably, while CP-AMPAR levels are low in NAc core MSN of drug-naïve rats, their 
contribution to synaptic transmission is increased (to ~25–30% of the evoked EPSC) after 
~40 days of withdrawal from extended-access self-administration of cocaine (18–23) and 
methamphetamine (present results). Furthermore, as observed for “cocaine incubated rats” 
(18,23), the expression of incubated methamphetamine craving was reduced either by 
blocking CP-AMPARs in the NAc core (via infusion of naspm) or by treating rats with a 
systemic injection of the mGlu1 PAM SYN119. The latter is a key finding as it indicates that 
mGlu1 PAM-based therapeutic approaches may be useful for prolonging abstinence in both 
cocaine and methamphetamine users. We note that SYN119 did not completely abolish 
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incubated methamphetamine craving (present results) or cocaine craving (23), consistent 
with evidence that incubation involves multiple mechanisms and brain regions (3–5).
For “cocaine incubated rats”, we have shown that the ability of systemic SYN119 to reduce 
craving was due to removal of CP-AMPARs from NAc synapses (23). Electrophysiological 
studies revealed that this removal involves dynamin-dependent CP-AMPAR internalization 
(30). It is likely that systemic SYN119 reduces incubated methamphetamine craving through 
the same mechanism, based on slice recordings in the present study demonstrating that bath-
applied SYN119 removes CP-AMPARs from NAc MSN of “methamphetamine incubated 
rats”. Furthermore, in other synapses that contain high levels of CP-AMPARs, mGlu1 PAMs 
similarly produce an inhibition of CP-AMPAR transmission that, in all cases tested, has 
been found to depend upon CP-AMPAR endocytosis (38–43). We note that effects of 
SYN119 in the ventral tegmental area may also contribute to decreased cocaine and 
methamphetamine seeking (44). Future studies should determine if elevated CP-AMPAR 
levels in the NAc of “methamphetamine incubated rats” result from increased GluA1 
expression and GluA1 homomer formation, as shown for cocaine (18,45). Interestingly, 
epigenetic mechanisms are implicated in altered AMPAR subunit expression after non-
contingent methamphetamine (46).
Based on studies of locomotor sensitization elicited by non-contingent cocaine and 
methamphetamine injections, it is perhaps surprising that common AMPAR adaptations in 
the NAc core are observed in the incubation model. Several groups have demonstrated 
increased surface and synaptic expression of GluA1A2-containing AMPARs in the NAc 
core after a week or so of withdrawal from repeated i.p. cocaine injections (for reviews, see 
5,47), while this does not occur in the NAc of rats sensitized to methamphetamine (48). 
However, it must be kept in mind that different plasticity often results from contingent 
versus non-contingent drug administration (for an example pertaining to 
methamphetamine’s effect on glutamate levels, see ref 49). On the other hand, there can be 
commonalities; thus methamphetamine self-administration decreased intrinsic excitability of 
MSN in the NAc shell during the first few days of withdrawal (50), and the same effect has 
been observed shortly after discontinuing cocaine self-administration (51) and even non-
contingent cocaine administration (for reviews, see 52,53). Future studies should evaluate 
effects of methamphetamine on intrinsic excitability in the NAc core, and examine potential 
relationships between methamphetamine-induced changes in intrinsic excitability and 
synaptic strength (53).
Incubation and CP-AMPAR plasticity occur more rapidly for methamphetamine than 
cocaine For cocaine, incubation of craving begins during the first week of withdrawal, 
continues to rise for 1–2 months and then remains high through at least WD90 before 
declining slowly (4,37). After a nearly identical cocaine regimen, CP-AMPAR levels in the 
NAc core remain at saline control levels for the first three weeks of abstinence, with an 
increase in CP-AMPAR levels first detected between WD25 and WD35; elevated levels are 
then maintained through at least WD90 (36). Once CP-AMPAR levels increase, their 
activation is required for expression of incubation of cocaine craving (18,23). The delayed 
onset of CP-AMPAR accumulation versus incubation of cocaine seeking indicates that other 
mechanisms must account for incubation during the first month of withdrawal, in keeping 
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with evidence that incubation involves complex circuitry beyond the NAc (see Introduction 
and 3–5).
We do not fully understand why a month of withdrawal elapses before CP-AMPAR levels 
rise. However, the rise in CP-AMPAR levels is preceded and enabled by a decrease in 
mGlu1 surface expression in the NAc core (23). Activation of mGlu1 removes CP-AMPARs 
from NAc synapses (20), so the withdrawal-dependent decrease in cell surface mGlu1 is 
thought to permit CP-AMPARs to accumulate in these synapses (23,31). In contrast, the 
present findings show that incubation of methamphetamine craving is complete by WD7, 
and that CP-AMPAR accumulation follows a parallel time course. The rapidity of incubation 
of Meth craving is confirmed by a very recent study (54). We speculate that more rapid 
incubation of methamphetamine craving may contribute to methamphetamine’s highly 
addictive nature. Future studies will determine whether more rapid CP-AMPAR 
accumulation after methamphetamine reflects a more rapid loss of mGlu1 surface expression 
in the NAc.
Methamphetamine and mGlu5
While less is known about mGlu1, it is well established that drugs targeting mGlu5 can 
affect addictive behaviors in animal models, with mGlu5 negative allosteric modulators 
(NAMs) suppressing responses to drugs including reinstatement of drug-seeking (55) while 
mGlu5 PAMs exert beneficial effects by facilitating extinction of drug-seeking behavior and 
reversing drug-induced cognitive deficits (56). Studies conducted after methamphetamine 
self-administration have similarly demonstrated both pro-cognitive effects of mGlu5 PAMs 
(57–59) and anti-relapse effects of mGlu5 NAMs (60). The latter effect was observed 
following limited-access methamphetamine self-administration and extinction training (60). 
It is unclear whether a similar effect would be observed in the incubation model, which 
utilizes extended-access self-administration and abstinence rather than extinction training, 
based on growing evidence that different circuits and glutamatergic adaptations are engaged 
when methamphetamine self-administration is followed by extinction training versus 
abstinence. For example, inactivation of similar regions of mPFC prevented reinstatement of 
methamphetamine seeking after extended-access methamphetamine self-administration and 
extinction training (16) but did not prevent expression of incubated methamphetamine 
seeking (11). Other examples of different plasticity after extinction versus abstinence, 
related to methamphetamine’s actions on basal glutamate levels (49,61) and mGlu2/3 
expression (62), are discussed in the next section. Similarly, it is well established that 
different neuroadaptations occur when cocaine self-administration is followed by extinction 
training versus abstinence (for example, 63–66). The self-administration regimen itself also 
determines subsequent neuroadaptations. For example, mGlu1 PAMs reduce expression of 
incubated cocaine seeking (23), whereas a recent study found that mGlu1 activation 
promoted drug primed-reinstatement of cocaine seeking after limited-access cocaine self-
administration and extinction training (67). The likely explanation for the difference is that 
limited-access cocaine self-administration in adult rats is not sufficient to elicit CP-AMPAR 
accumulation (21), so there is no substrate for mGlu1-induced synaptic depression and 
therefore no suppression of NAc output (20,22,23).
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It will also be important to examine the effect of methamphetamine self-administration on 
mGlu5 expression and function, given that “cocaine incubated rats” show impaired mGlu5-
induced synaptic depression (20) and a small decrease in mGlu5 surface expression in the 
NAc after prolonged withdrawal (23; but see ref 65 for different results after limited-access 
cocaine self-administration). Non-contingent methamphetamine administration does not 
affect mGlu5 levels in the NAc, although mGlu5 expression is altered in other regions 
(48,68).
Methamphetamine and presynaptic glutamate function
While the present study focused on postsynaptic adaptations, methamphetamine self-
administration may also alter presynaptic glutamate function. No-net flux microdialysis 
studies have detected changes in basal glutamate levels that are opposite in direction 
depending on whether methamphetamine self-administration is followed by abstinence (49) 
or extinction (61). A history of methamphetamine self-administration also influences 
glutamate efflux in response to methamphetamine re-exposure (49,61). Presynaptic mGlu2/3 
receptors are also implicated in methamphetamine seeking. Their activation reduces 
incubated methamphetamine seeking (10), motivation to self-administer methamphetamine 
(69), and cue or methamphetamine-induced reinstatement of methamphetamine seeking 
after extinction training (70). Interestingly, extended-access methamphetamine self-
administration followed by 14 days of abstinence decreased mGlu2/3 levels in the NAc, 
whereas this was not observed after extinction training (62).
Conclusions
The incubation of drug craving model is relevant to understanding persistent vulnerability to 
cue-induced drug craving and relapse in recovering addicts (4,5,37,71). The present study is 
the first to demonstrate a role for the NAc in the expression of incubated methamphetamine 
craving. Combined with previous results on the incubation of cocaine craving (23), our 
results suggest that recovering methamphetamine or cocaine addicts could use mGlu1 PAMs 
prophylactically prior to entering a situation which might provoked cue-induced drug 
craving. This would help them maintain abstinence for a longer period of time. No drug is 
presently available that provides such protection. Demonstrating that the potential utility of 
mGlu1 PAMs extends to both cocaine and methamphetamine addiction enhances the 
justification for testing this strategy in clinical studies.
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Incubation of methamphetamine craving. (A) Timeline of the experimental procedure. Rats 
were trained to self-administer methamphetamine for 6 h/day for a total of 10 days, and 
tested for cue-induced methamphetamine craving on either WD1 or WD45. (B) Training 
phase: Mean ± SEM number of methamphetamine infusions (top) and number of active hole 
(AH) and inactive hole (IH) nose-pokes (bottom) over the ten, 6-h daily self-administration 
training sessions (n=26 total rats). (C) Seeking tests: Data are mean ± SEM nose-pokes in 
the previously active hole and in the inactive hole during the seeking tests on WD1 (n=13 
rats) and WD45 (n=13 rats). During the seeking tests, active hole nose-pokes led to 
contingent presentation of a 20-sec light cue previously paired with each methamphetamine 
injection. Meth, methamphetamine; SA, self-administration; WD, withdrawal day.
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The incubation of methamphetamine craving is accompanied by accumulation of CP-
AMPARs in NAc core synapses and emergence of robust mGlu1-mediated synaptic 
depression. (A) Timeline of the experimental procedure (see legend to Figure 1 for details). 
(B) Bath application of the CP-AMPAR antagonist naspm (100 μM) produced a significantly 
greater reduction in EPSC−70mV in MSN from methamphetamine rats (WD>40) as 
compared to saline controls (24.3% vs. 8.8%; calculated from min 9–12 after naspm 
application, as shown in shaded region; p<0.05) (methamphetamine, n=8 cells/5 rats; saline, 
n=6 cells/4 rats). (C) In MSN from methamphetamine rats (>WD40), application of the 
mGlu1 positive allosteric modulator SYN119 (SYN; 1μM) induced a robust depression of 
the EPSC−70mV (28%), and subsequent application of naspm had no further effect (based on 
comparison of shaded regions: last 4 min of SYN alone versus last 4 min of naspm). Scale 
bars: 40 ms × 100 pA.
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Systemic administration of the mGlu1 positive allosteric modulator SYN119 reduces 
incubated cue-induced methamphetamine seeking. (A) Timeline of the experimental 
procedure (see legend to Figure 1 for details). (B) Training phase: Mean ± SEM number of 
methamphetamine infusions, active hole and inactive hole nose-pokes over the ten, 6-h daily 
self-administration training sessions (n=20 total rats). (C) Seeking test: Data are mean ± 
SEM nose-pokes in the previously active hole and in the inactive hole during seeking tests 
on or after WD40. SYN119 or vehicle was injected (10 mg/kg, i.p.) 20 min prior to the 
seeking test. SYN119 significantly reduced cue-induced methamphetamine seeking 
compared to vehicle-injected controls (*p<0.05).
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Blockade of CP-AMPARs in the NAc core with naspm reduces incubated cue-induced 
methamphetamine seeking. (A) Timeline of the experimental procedure (see legend to 
Figure 1 for details). (B) Training phase: Mean ± SEM number of methamphetamine 
infusions (top) and number of active hole (AH) and inactive hole (IH) nose-pokes (bottom) 
over the ten, 6-h daily self-administration training sessions (n=26 total rats). (C) Seeking 
test: Shown are nose-pokes in the previously AH and in the IH during a seeking test on 
WD45. Naspm (n=14 rats) or vehicle (n=12 rats) was injected into the NAc core 15 min 
prior to the seeking test. Naspm significantly reduced cue-induced methamphetamine 
seeking compared to vehicle-injected controls (*p<0.05). Data are expressed as percent of 
vehicle group (mean ± SEM); note that both AH and IH responses for the vehicle group are 
set at 100%. Data are presented in this manner because we combined results from two 
different experiments (done years apart) with substantially different raw values for AH and 
IH nose-pokes during the seeking test [Experiment 1: veh group (n=7), AH: 40.4 ± 9.1, IH: 
10.0 ± 3.1; naspm group (n=10), AH: 23.4 ± 3.2, IH: 9.8 ± 1.7; Experiment 2: veh group 
(n=5), AH: 16.4 ± 1.3, IH: 4.8 ± 0.6; naspm group (n=4), AH: 11.8 ± 3.2, IH: 4 + 0.9].
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Incubation of methamphetamine craving and CP-AMPAR accumulation in NAc core 
synapses reach maximal levels by withdrawal day 7–8. (A) Timeline of experimental 
procedures for results shown in panel B (see legend to Figure 1 for details). (B) The 
reduction in EPSC−70 produced by bath application of the CP-AMPAR antagonist naspm 
(100 μM) was used to define the contribution of CP-AMPARs to synaptic transmission in 
methamphetamine rats recorded on different withdrawal days (WD). The left graph 
compares the effect of naspm in MSN recorded on WD1 (n=6 cells/4 rats) versus WD7–8 
(n=5 cells/4 rats) (data are mean ± SEM). For sample traces, scale bars indicate 40 ms × 100 
pA. The bar graph on the right summarizes data from WD1 and WD78, as well as from 
WD2–4 (n=5 cells/4 rats) and WD>40 (n=8 cells/5 rats) (the latter data are taken from 
Figure 2). Data in the right graph are expressed as % reduction in EPSC−70 after naspm 
(average of min 9–12 after naspm; this period is indicated by gray shading in the left graph) 
(*p<0.05). (C) Timeline of experimental procedures for results shown in panels D and E (see 
legend to Figure 1 for details). (D) Training phase: Mean ± SEM number of 
methamphetamine infusions, active hole and inactive hole nose-pokes over the ten, 6-h daily 
self-administration training sessions (n=12 rats). (E) Seeking test: Each rat was tested twice, 
on WD7 and WD30. Data are mean ± SEM nose-pokes in the previously active hole and in 
the inactive hole during seeking tests.
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